Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-02 22:09:01 - browse：43832

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Medicare Advantage enrollment hits roughly 33.4 million

hotspot

explore

WSS

In 'major milestone,' FDA approves first cell therapy for solid tumors

WATCH: Why do our ears pop?

Listen: Vivek Ramaswamy's star turn & leaky drug data

Congress may force more Covid

WATCH: Why do our ears pop?

New study raises questions about niacin and heart health

hotspot

Wikipedia

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Flagship Pioneering startup Sonata Therapeutics lays off 21

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Dobbs anniversary: the lost opportunity of abortion as health care

How to make over

Activists slam private health insurers over coverage restrictions

MD Anderson's Padmanee Sharma responds to research credit suit

At least 13 dead in Texas as scorching temps continue

Intellia plays down concerns on accidental germline transmission

explore

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Congress may force more Covid

Republicans love RFK Jr. What's that tell us about health in 2024?

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

In 'major milestone,' FDA approves first cell therapy for solid tumors

How to make over

Wikipedia

hotspot

explore

hotspot